FDA inspection

Shandong Qilu King-phar Pharmaceutical Co., Ltd.: FDA inspection ending Apr 24, 2015

FDA inspection 928475 · No Action Indicated (NAI) · Jinan

Key facts

Inspection ID 928475
Firm Shandong Qilu King-phar Pharmaceutical Co., Ltd.
FEI number 3003657816
Address No. 21 Qinglonglu, Pingyinxian
City Jinan
Country China
Fiscal year 2015
Inspection end date Apr 24, 2015
Classification No Action Indicated (NAI)
Project area Monitoring of Marketed Animal Drugs, Feed, and Devices
Product type Veterinary

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections